| Vitamin E enhances cancer immunotherapy by reinvigorating dendritic cells via targeting checkpoint SHP1 X Yuan, Y Duan, Y Xiao, K Sun, Y Qi, Y Zhang, Z Ahmed, D Moiani, J Yao, ... Cancer discovery 12 (7), 1742-1759, 2022 | 43 | 2022 |
| A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer K Sun, Y Xu, L Zhang, P Niravath, J Darcourt, T Patel, BS Teh, AM Farach, ... Clinical Cancer Research 28 (20), 4392-4401, 2022 | 13 | 2022 |
| Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib K Sun, S Kasparian, S Iyer, SR Pingali ecancermedicalscience 12, 2018 | 8 | 2018 |
| A phase II trial of stereotactic radiation therapy and in situ oncolytic virus therapy in metastatic triple-negative breast cancer (mTNBC) patients followed by … K Sun, JE Ensor, Y Xu, L Zhang, C Guerrero, PA Niravath, TA Patel, ... Journal of Clinical Oncology 39 (15_suppl), 1079-1079, 2021 | 7 | 2021 |
| Stereotactic body radiation therapy and in situ oncolytic virus therapy followed by immunotherapy in metastatic non-small cell lung cancer. C Guerrero, JE Ensor, K Sun, AM Farach, S Nair, J Zhang, M Singh, ... Journal of Clinical Oncology 39 (15_suppl), 9115-9115, 2021 | 6 | 2021 |
| Pancreatic head vs pancreatic body/tail cancer: Are they different? K Sun, C Mylavarapu, A Crenshaw, Y Zhang, E Hsu, J Xu, M Niravath, ... World Journal of Gastrointestinal Oncology 14 (3), 716, 2022 | 5 | 2022 |
| Acute myeloid leukaemia presenting as acute liver failure—a case report and literature review K Sun, RJ Reynolds, TG Sheu, JA Tomsula, L Colton, L Rice ecancermedicalscience 13, 2019 | 5 | 2019 |
| Use of PEG-asparaginase in a case of Hepatosplenic γδ T-cell lymphoma with long-term remission after stem cell transplantation K Sun, CG Sanchez, SR Pingali, S Iyer ecancermedicalscience 12, 2018 | 3 | 2018 |
| Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer EA Burns, K Gee, RB Kieser, J Xu, Y Zhang, A Crenshaw, IN Muhsen, ... Cancers 15 (1), 81, 2022 | 2 | 2022 |
| Outcomes of patients with advanced urothelial cancer who develop infection while on treatment with pembrolizumab. RB Kieser, J Xu, E Burns, I Muhsen, SM Shah, G Umoru, C Mylavarapu, ... Journal of Clinical Oncology 40 (16_suppl), 4573-4573, 2022 | 1 | 2022 |
| Infections and their impact on patients on pembrolizumab-based therapies for head and neck cancer. Y Zhang, J Xu, I Muhsen, E Burns, SM Shah, G Umoru, C Mylavarapu, ... Journal of Clinical Oncology 40 (16_suppl), 6035-6035, 2022 | 1 | 2022 |
| Infections in Patients with Myelodysplastic Syndrome. Looking for the Escape Clause! CG Sanchez, Q Qin, K Sun, J Ensor, M Puppala, S Wong, IF Ibrahim, ... Blood 130, 1694, 2017 | 1 | 2017 |
| Neighborhood Walkability Is Associated With Lower Burden of Cardiovascular Risk Factors Among Cancer Patients N Nwana, OM Makram, JC Nicolas, A Pan, R Gullapelli, T Parekh, ... JACC: CardioOncology, 2024 | | 2024 |
| Abstract PO5-12-09: A Single-Arm Pilot Study of the Feasibility and Efficacy of Electro-Acupuncture in Subjects with Chemotherapy-Induced Peripheral Neuropathy N Vobugari, JP Liang, L Savage, D Jain, K Sun, H Mai, J Chang, M Desai, ... Cancer Research 84 (9_Supplement), PO5-12-09-PO5-12-09, 2024 | | 2024 |
| 5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer J Shao, Y Xu, RJ Olsen, S Kasparian, K Sun, S Mathur, J Zhang, C He, ... Cells 13 (8), 715, 2024 | | 2024 |
| Abstract CT029: Chemotherapy-free neoadjuvant regimen with durvalumab, trastuzumab and pertuzumab (DTP) in HER2-enriched early breast cancer: A prospective, open-label phase II … J Guan, K Sun, D Jain, S Mathur, H Mai, P Niravath, J Chang Cancer Research 84 (7_Supplement), CT029-CT029, 2024 | | 2024 |
| A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer J Guan, K Sun, CA Guerrero, J Zheng, Y Xu, S Mathur, BS Teh, A Farach, ... International Journal of Radiation Oncology* Biology* Physics 118 (5), 1531-1540, 2024 | | 2024 |
| Racial disparity in HER2-positive breast cancer: A single cancer center registry review A Hodges, C Rosenbaum, C Santana, PA Niravath, H Mai, D Jain, ... Cancer Research 84 (6_Supplement), 6113-6113, 2024 | | 2024 |
| 451 Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving Atezolizumab J Xu, E Burns, K Gee, C Wiechmann, Y Zhang, R Kieser, G Umoru, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 1233 Impact of infections occurring in patients receiving immune checkpoint inhibitors for renal cell carcinoma (RCC) C Wiechmann, K Gee, E Burns, J Xu, Y Zhang, A Crenshaw, A Esmail, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
